Anandron (RU 23908) in metastatic prostate cancer: preliminary results of a multicentric Italian study.

Boccardo, F

Anandron (RU 23908) in metastatic prostate cancer: preliminary results of a multicentric Italian study. [electronic resource] - Cancer detection and prevention 1991 - 501-3 p. digital

Publication Type: Clinical Trial; Journal Article; Multicenter Study

0361-090X


Aged
Aged, 80 and over
Androgen Antagonists--adverse effects
Antineoplastic Agents--adverse effects
Humans
Imidazoles--adverse effects
Imidazolidines
Male
Middle Aged
Neoplasm Staging
Prostatic Neoplasms--drug therapy
Vision Disorders--chemically induced